People with psoriasis and psoriatic arthritis, collectively known as psoriatic disease, are more likely to develop cardiovascular disease than others in the general population. In a new study published in Arthritis & Rheumatology ...
Mar 9, 2022
0
5
Empagliflozin reduces the risk of a composite of cardiovascular death or hospitalization for heart failure in patients with heart failure and a preserved ejection fraction (HFpEF) with or without diabetes. That's the finding ...
Aug 27, 2021
0
176
(HealthDay)—Dietary interventions, like the Dietary Approaches to Stop Hypertension (DASH) diet and low sodium consumption, can improve cardiovascular risk factors in a relatively short time period, according to a study ...
Jun 17, 2021
0
6
In a recent study published in the Journal of the American Heart Association by University of Alabama at Birmingham researchers, findings indicate that among patients with heart failure, obesity is associated with a higher ...
Apr 5, 2021
0
51
Sacubitril/valsartan reduces NT-proBNP, a biomarker predictive of long-term clinical outcomes in heart failure, but does not improve functional capacity compared to individualized background therapy in patients with heart ...
Aug 31, 2020
0
4
(HealthDay)—For adult emergency department (ED) patients with syncope, serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) does not improve prognostication above the Canadian Syncope Risk Score (CSRS), according ...
Apr 30, 2020
0
0
Assessing preoperative levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), a biomarker of heart stress and structural changes, may improve risk prediction beyond the clinical risk score in patients having noncardiac ...
Dec 25, 2019
0
3
A hormone found in the blood that's commonly linked to heart disease also might signal when someone is more likely to grow weaker or lose their ability to balance before they're 70.
Jan 22, 2019
1
16
Researchers at the University of Birmingham have found two biomarkers that could be used to identify a heart condition known as atrial fibrillation in patients who have three 'clinical risks'.
Jan 7, 2019
0
89
There are currently many kinds of drugs for heart failure. Among them, the new drug LCZ696 is recommended by US guidelines as a first-line treatment for chronic heart failure. LCZ696 is better than conventional drugs at reducing ...
Oct 2, 2017
0
0
